(ANSA) – ROME, SEPTEMBER 17 – Moderate consumption of coffee and caffeinated beverages is good for metabolic health, reducing the risk of diabetes, coronary heart disease and stroke.
This is revealed by a study published in the Journal of Clinical Endocrinology & Metabolism.
In summary, it emerged that regular intake of coffee or caffeine, especially at moderate levels, is associated with a reduced risk of cardiometabolic multimorbidity (CM), which refers to the coexistence of at least two cardiometabolic diseases.
“Consuming three cups of coffee or 200-300 mg of caffeine per day may help reduce the risk of developing cardiometabolic multimorbidity,” says study lead author Chaofu Ke of Suzhou Medical College of Soochow University in China.
The study found that compared with non-consumers or those consuming less than 100 mg of caffeine per day, consumers of moderate amounts of coffee (3 cups per day) or caffeine (200-300 mg per day) had a 48.1% or 40.7% reduced risk of developing cardiometabolic multimorbidity.
The experts analyzed data from the British Biobank, on more than 500,000 participants aged 37-73. The final group of participants included a total of 172,315 people without cardiometabolic diseases for the analysis of caffeine, and 188,091 for the analysis of coffee and tea consumption.
Coffee and caffeine consumption at all levels were inversely associated with the risk of cardiometabolic multimorbidity. Those who reported moderate coffee or caffeine consumption had the lowest risk. Moderate coffee or caffeine intake was inversely associated with nearly all stages of cardiometabolic multimorbidity development.
“The findings highlight that promoting moderate coffee or caffeine consumption as a dietary habit among healthy people could have significant benefits for the prevention of CM,” says Ke. (ANSA).
2024-09-17 13:18:22